Abbott Laboratories posted slightly better-than-expected second-quarter earnings and raised its full-year profit outlook.
Wall Street still prices Abbott like a dividend stalwart, but overlooked moves suggest that framing may be costing investors ...
Abbott is down nearly 23% this year while Pfizer dangles a 7% yield, and both just beat Q1 estimates. One of these discounts ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.
Morning Overview on MSN
A new wearable tracks both blood sugar and ketones from a single sensor
People with diabetes who need to track both glucose and ketone levels have long juggled separate devices, pricking their ...
Tandem Diabetes Care (TNDM) is back in focus after announcing that its t:slim X2 insulin pump with Control-IQ+ technology now ...
Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, ...
TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar reduced the firm’s price target on Abbott Laboratories to ...
Becton, Dickinson is a medical device manufacturer. The company has a large product portfolio, many of which are used daily by healthcare facilities. Becton, Dickinson is benefiting from the GLP-1 ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Check out the latest Abbott Laboratories (ABT) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results